Verséa Diagnostics is a Full-service partner offering a diversified range of innovative and high-quality testing solutions. We have a unique ability to offer solutions that fit the needs of every one of our partners, regardless of their type, size, licensing level, or budget.
As a company created by physicians for physicians, we understand the need to be up to date with new diagnostic discoveries.
Our long-lasting partnerships with world-wide manufacturing leaders as well as R&D alliances with Clinical Research Organizations (CROs) provide optimal benefits to our partners.
Verséa is also able to assist with product registrations and distribution into healthcare provider segments outside of the United States including: Canada, Mexico, South America, India.
Our Point-of-Care (POC) Professional portfolio consists of CLIA-waved, FDA cleared/EUA approved testing solutions for:
- Infectious diseases (COVID-19, Flu A/B, RSV, Strep, Mono, HIV-1/2, HCV)
- Non-infectious diseases
- Pregnancy & Ovulation
- Urinalysis
- Drugs of abuse testing (urine & oral fluid)
- Allergy testing (minimally invasive)
- Biomarkers (Colon Cancer Screening)
